The deadline for a call for proposals for projects on research to combat the COVID-19 pandemic was June 16. The call is a collaborative effort between research funders from the Nordic countries, Estonia and Latvia.
Based on an initiative from the deans of the Nordic medical schools, the Joint Committee of the Nordic Medical Research Councils (NOS-M) has decided to fund a Nordic online course for medical students in personalised medicine.
The ongoing COVID-19 pandemic is generating a widespread need for new knowledge relating to the spread of the SARS-CoV-2 virus. Four new collaborative projects will now use health data to learn more about the virus.
NORDeHEALTH aims to implemented to give patients online access to their electronic health records (PAEHR) and increase self-management and transparencyin healthcare. The goal is to enable further digitalization of the public health sector by providing concrete feedback to the national. authorities in the respective countries, provide guidelines and frameworks for design, implementation and evaluation of personal eHealthservices (PeHS).
The aims of the ALLTogether study are to improve survival and quality of survival for children and young adults with ALL. ALL in young people has excellent outcome with >90% survival in children and about 75% in young adults. However, patients still die of diseases after relapse as a result of under-treatment.
Rheumatoid arthritis (RA, life-time risk around 2%) entails a considerable burden for affected individuals (pain, reduced life-span, reduced function, reduced quality of life), for health-care, and for society (reduced work ability, and treatment costs that currently accounts for almost 10% of the total drug expenditure). Delayed or ineffective treatment leads to joint destruction, co-morbidities, and increased mortality.v
The PERAID project proposes to implement personalized medicine (PM) in severe infectious diseases, specifically focusing on the life-threatening necrotizing soft tissue infections (NSTI) as well as the large heterogeneous group of sepsis patients.
Globally, the leading cause of years of life lost is ischemic heart disease (IHD). In the EU 13.2 mio. patients are diagnosed with IHD(1) of these 700,000 live in the Nordic countries. IHD causes chest pain, myocardial infarcts, reduced physical capacity and reduces life-expectance. IHD is considered a chronic disease and may progress despite current optimal treatment.